Health Care/Hospital

Whiz Gambit now available across EMEA

HONG KONG, Sept. 10, 2021 /PRNewswire/ -- As the world navigating the new normal, effective cleaning and disinfection practices have never been more important. In response to the growing demand, Whiz Gambit, the 2-in-1 AI-powered cleaning and disinfection robotic solution, jointly launched by So...

2021-09-10 11:00 2369

DiaCarta Receives CE/IVD for its New COVID 19 Screening Test that Identifies Delta Plus and New Variants

PLEASANTON, Calif., Sept. 10, 2021 /PRNewswire/ -- DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel oncology tests using liquid biopsy today announced that its new QuantiVirus™ SARS-CoV-2 Variant Detection Test received the CE/IVD marking and therefore, can ...

2021-09-10 02:02 2089

Nature Scientific Reports publishes novel AI technique that can automatically detect poor-quality medical data and improve healthcare AI and data privacy

SAN FRANCISCO, Sept. 9, 2021 /PRNewswire/ -- A recent paper in the journal Nature Scientific Reports shows that Artificial Intelligence (AI) can automatically detect errors in poor-quality medical data, even errors that are difficult for medical experts to manually identify. The innovative algor...

2021-09-09 22:41 2160

Medigate and CrowdStrike to Provide Healthcare Organizations with Unified Endpoint Security for Medical IoT Devices

Integration enables comprehensive visibility, enhanced risk management and security enforcement BROOKLYN, N.Y., Sept. 9, 2021 /PRNewswire/ -- Medigate, healthcare's Best in KLAS IoT Security Provider, today announced it has partnered with CrowdStrike, a leading provider of cloud-delivered e...

2021-09-09 21:00 1869

Winners Of The 2022 Breakthrough Prizes In Life Sciences, Fundamental Physics And Mathematics Announced

$15.75 Million in Prizes Awarded for Discoveries Leading to Covid-19 Vaccines, Treatments For Neurological Diseases, Unprecedentedly Precise Quantum Clocks, and Other Major Discoveries Breakthrough Prize in Life Sciences Awarded to Shankar Balasubramanian, David Klenermanand Pascal Mayer; Katali...

2021-09-09 20:24 2460

Sofwave Medical Appoints Assaf Korner as Chief Financial Officer

TUSTIN, Calif., Sept. 9, 2021 /PRNewswire/ -- Sofwave Medical LTD (TASE: SOFW) ("Sofwave" or the "Company"), a medical device aesthetic innovator in the non-invasive skin treatments, today announced the appointment of Assaf Korner as Chief Financial Officer, succeedingMichael Eden effective Septem...

2021-09-09 20:11 1776

Three Aon Colleagues Recognized as HERoes Women Role Models by INvolve

CHICAGO, Sept. 9, 2021 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm providing a broad range of risk, retirement and health solutions, is proud to announce that three colleagues were named to the HERoes Women Role Model Lists for 2021. Jennifer Bell, CEO, North...

2021-09-09 20:00 5624

Clover Biopharmaceuticals Receives Pharmaceutical Manufacturing Permit from Zhejiang Medical Products Administration to Produce COVID-19 Vaccine

CHENGDU, China, Sept. 9, 2021 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover) , a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced that its wholly-owned subsidiary, Zhejiang Clover...

2021-09-09 19:51 1900

ABILITY Diabetes Global enrolls thousandth patient: A Cardinal Milestone Achieved

TAMPA, Fla., Sept. 9, 2021 /PRNewswire/ -- ABILITY Diabetes Global  (Randomized Comparison ofAbluminus DES+ Sirolimus-Eluting Stents versus Everolimus-Eluting Stents in Coronary Artery Disease Patients with Diabetes Mellit...

2021-09-09 19:26 2191

PAQ Therapeutics Announces Collaboration with Insilico Medicine to Develop Novel Therapies through Autophagy-Dependent Degradation

CAMBRIDGE, Mass., Sept. 9, 2021 /PRNewswire/ -- PAQ Therapeutics ("PAQ"), a biotechnology company harnessing the power of autophagy to restore health and cure disease, and Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery company, today announced tha...

2021-09-09 19:20 1842

Proximie Partners with Teladoc Health to Connect Operating Rooms Globally

Proximie software to be integrated in Teladoc Health's Solo™ platform ecosystem for hospitals and health systems, enabling an integrated experience for surgeons BOSTON, Sept. 9, 2021 /PRNewswire/ -- Proximie, a health technology platform focused on digitizing operating and diagnostic rooms, today...

2021-09-09 19:00 2063

AIA Live Returns For 2021: Helping People Live Healthier, Longer, Better Lives

HONG KONG, Sept. 9, 2021 /PRNewswire/ -- AIA's Global Ambassador David Beckham talks "Tai Chi" and mental health as he joins fellow AIA health and wellness ambassadors, industry experts and leading influencers from acrossAsia for AIA Live 2021. The inaugural AIA Live 2020, which streamed on AIA'...

2021-09-09 18:46 1944

China's Northernmost Free Trade Zone Sees Wider Reform and Opening-up

HARBIN, China, Sept. 9, 2021 /PRNewswire/ -- August 30 marks the second anniversary of the establishment of Harbin sub-area ofHeilongjiang pilot free trade zone (FTZ). Over the past two years, a total of 8,787 new enterprises have been established inHarbin sub-area. Nearly one-third of the enterp...

2021-09-09 18:12 1882

A premium Korean red ginseng brand, CheongKwanJang's KGC, commemorates the 122nd anniversary of its industry entry

SEOUL, South Korea, Sept. 9, 2021 /PRNewswire/ -- KGC, owning a Korean premium red ginseng brand CheongKwanJang, celebrated the 122nd anniversary of its industry entry. The world's best Korean ginseng becomes a luxury red ginseng, Birth of 'CheongKwanJang' The government-run management system...

2021-09-09 15:41 5492

Gan & Lee Pharmaceuticals to present data at the 57th Annual European Association for the Study of Diabetes Meeting

BEIJING and BRIDGEWATER, N. J., Sept. 9, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is excited to present positive data from five abstracts which will be featured as short oral discussions at the 57th Annual European Ass...

2021-09-09 15:00 1931

Nanoform technology delivers successful results for Herantis CDNF drug candidate

HELSINKI, Sept. 9, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc ("Herantis"), focusing on disease modifying therapies for debilitating neurodegenerative diseases based on the natural body protein CDNF (Cerebr...

2021-09-09 14:04 1571

WCLC 2021 | Mini Oral - Ascentage Pharma Announces Latest Data of Its Investigational Bcl-2/Bcl-xL Inhibitor Pelcitoclax (APG-1252) Combined with Osimertinib in Patients with EGFR TKI-Resistant Non-Small Cell Lung Cancer

SUZHOU, China, and ROCKVILLE, MD., Sept 9, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today reported the Phase Ib results of the dual Bcl-2/Bcl-xL inhi...

2021-09-09 08:26 5011

CStone presents registrational bridging study data for GAVRETO® (pralsetinib) highlighting efficacy and safety in Chinese patients with advanced RET fusion-positive non-small cell lung cancer at IASLC WCLC 2021

SUZHOU, China, Sept. 9, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on researching, developing and commercializing innovative immuno-oncology therapies and precision medicines, today announced that efficacy and safety data from a...

2021-09-09 08:00 3033

HaemaLogiX raises $10 million to advance multiple myeloma treatments

* HaemaLogiX completes a fully subscribed $10 million share placement and welcomes Platinum Asset Management as core new institutional investor within its Platinum International Health Care Fund * Funding underpins HaemaLogiX's drug development pipeline, targeting multiple myeloma - the sec...

2021-09-09 05:00 1850

Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza

-- First participants enrolled in Phase 1 clinical trial of combination NanoFlu™/NVX–CoV2373 vaccine with Matrix-M™ adjuvant -- Phase 1/2 study will evaluate immunogenicity and safety GAITHERSBURG, Md., Sept. 8, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated...

2021-09-08 20:30 4760
1 ... 288289290291292293294 ... 553